Covid Test Risk Management Recommendations
Information for Providers: Testing Healthcare Personnel for SARS-CoV-2: Information for Providers
FAQs for Covid Test Recipients: FAQs Covid Test
Patient Consent for Covid Test: Patient Consent for Covid Test
Employee Consent for Covid Test: Employee Consent for Covid Test
DURYSTA Implant
The FDA approved the DURYSTA implant in June 2020 for the treatment of open-angle glaucoma. DURYSTA.Recommendations and consent discusses the risk of endothelial cell loss (ECL), and provides a sample consent form to help educate patients about the risks and benefits. Both the recommendations and consent form address implanting more than one DURYSTA per eye.
Triesence consent form
This consent form for Triesence should be reviewed and revised as needed.
RECOMMENDATIONS: Kenalog and Triesence intravitreal injections
PREVENT WRONG EVENTS: Time out before Intravitreal Injections
